Literature DB >> 30236191

HIV screening of tuberculosis patients in Portugal: what are we missing?

L Ribeiro1, M Gomes2, R Gaio3, R Duarte4.   

Abstract

BACKGROUND: Knowledge of human immunodeficiency virus (HIV) status is essential to effectively manage both tuberculosis (TB) and HIV infection. This is why the World Health Organization (WHO) recommends routine HIV testing in all TB patients.
OBJECTIVE: To determine the number of TB patients with unknown HIV status in Portugal and to identify the factors associated with unknown HIV status.
METHODS: A retrospective study of all TB notifications from 2008 to 2014 in Portugal was conducted. A multiple logistic regression model was used to evaluate the association of sociodemographic and clinical factors with unknown HIV status.
RESULTS: We examined the records of 18 445 patients with TB notification, 2402 of whom (13%) had unknown HIV status. Unknown HIV status was positively associated with age 65 years (adjusted odds ratio [aOR] 1.208, 95%CI 1.037-1.408) and extra-pulmonary TB (aOR 1.381, 95%CI 1.252-1.523), but negatively associated with unemployment (aOR 0.755, 95%CI 0.637-0.895), alcohol dependence (aOR 0.809, 95%CI 0.682-0.959) and drug dependence (aOR 0.566, 95%CI 0.449-0.713).
CONCLUSION: Risk perception is the most important barrier to complete knowledge of HIV status in TB patients in Portugal. Given the importance of HIV screening in TB patients, every effort should be made to ensure that all TB patients undergo HIV screening.

Entities:  

Mesh:

Year:  2018        PMID: 30236191     DOI: 10.5588/ijtld.17.0846

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  1 in total

1.  Current evidence on the adoption of indicator condition guided testing for HIV in western countries: A systematic review and meta-analysis.

Authors:  S J Bogers; S H Hulstein; M F Schim van der Loeff; G J de Bree; P Reiss; J E A M van Bergen; S E Geerlings
Journal:  EClinicalMedicine       Date:  2021-05-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.